Natera, Inc. (NASDAQ:NTRA) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Michael Brophy ??? Chief Financial Officer Steve Chapman ??? Chief Executive Officer Solomon Moshkevich ??? General Manager of Oncology Conference Call Participants Tejas Savant ??? Morgan Stanley Tycho Peterson ??? JPMorgan Doug Schenkel ??? Cowen Puneet Souda ??? SVB Leerink Mark Massaro ??? BTIG Rachel Vatnsdal ??? Piper Sandler Alex Nowak ??? Craig-Hallum Operator Welcome to Natera's 2021 First Quarte ...

natera Natera, Inc. Investor presentation May 2021 Q1 2021 earnings call Ⅹ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ × × × × × × × × × Ⅹ Ｘ × × X X X X X X X X × × X X X X X X X × × Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ⅹ Ｘ × × × × × × × × Safe harbor statement This presentation contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation, including statements regarding the market opportu ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37478 NATERA, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 01-0894487 (State or Other ...

Natera, Inc. (NASDAQ:NTRA) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants Michael Brophy - Chief Financial Officer Steve Chapman - Chief Executive Officer Matt Rabinowitz - Co-Founder & Chairman Solomon Moshkevich - General Manager of Oncology Conference Call Participants Tejas Savant - Morgan Stanley Tycho Peterson - JPMorgan Doug Schenkel - Cowen Catherine Schulte - Baird Operator Welcome to Natera's 2020 Fourth Quarter and Full Year 2020 Financial Results Conference Ca ...

natera Natera, Inc. Investor presentation February 2021 Q4 2020 earnings call Ⅹ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ X X X X X X X X x X X X X X X X Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ Ｘ × × Safe harbor statement This presentation contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation, including statements regarding the market opportunity, produ ...

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR For the transition period from to Commission file number: 001-37478 NATERA, INC. 13011 McCallen Pass Building A Suite 100 Austin, TX 78753 (Address of Principal Executive Offic ...

Natera, Inc. (NASDAQ:NTRA) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Steve Chapman - Chief Executive Officer Michael Brophy - Chief Financial Officer Solomon Moshkevich - General Manager, Oncology Paul Billings - Chief Medical Officer Conference Call Participants Subhalaxmi Nambi - Cowen Eleni Apostolatos - JPMorgan Puneet Souda - SVB Leerink Catherine Schulte - Baird Max Masucci - Canaccord Genuity Alex Nowak - Craig-Hallum Capital Mark Massaro - BTIG Operator Welcom ...

| --- | --- | |-------------------------------------------------------|-------| | | | | Natera, Inc. Third Quarter 2020 Earnings Presentation | | | November 5, 2020 | | 1 Not for reproduction or further distribution. Safe harbor statement This presentation contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation, including statements regarding the market opportunity, ...

(Mark One) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37478 NATERA, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 01-0894487 (State or O ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37478 NATERA, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 01-0894487 (State or Other ...